Sue Currie

2.7k total citations · 1 hit paper
35 papers, 1.9k citations indexed

About

Sue Currie is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Sue Currie has authored 35 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 17 papers in Hepatology and 12 papers in Infectious Diseases. Recurrent topics in Sue Currie's work include Hepatitis C virus research (17 papers), Hepatitis B Virus Studies (15 papers) and Liver Disease Diagnosis and Treatment (11 papers). Sue Currie is often cited by papers focused on Hepatitis C virus research (17 papers), Hepatitis B Virus Studies (15 papers) and Liver Disease Diagnosis and Treatment (11 papers). Sue Currie collaborates with scholars based in United States, Canada and Italy. Sue Currie's co-authors include Martin T. Schechter, David M. Patrick, Peter Cornelisse, Michael L. Rekart, Steffanie A. Strathdee, Mark Tyndall, Kathy Li, M. V. O'Shaughnessy, Michael V. O’Shaughnessy and Julio Montaner and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Hepatology.

In The Last Decade

Sue Currie

34 papers receiving 1.8k citations

Hit Papers

Needle exchange is not enough 1997 2026 2006 2016 1997 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sue Currie United States 15 1.7k 765 646 567 219 35 1.9k
Norah Palmateer United Kingdom 24 2.1k 1.3× 782 1.0× 1.1k 1.8× 788 1.4× 155 0.7× 54 2.3k
Lisette Johnson United States 9 1.2k 0.7× 664 0.9× 811 1.3× 137 0.2× 151 0.7× 9 1.6k
Pascale Leclerc Canada 18 756 0.5× 334 0.4× 223 0.3× 191 0.3× 162 0.7× 38 1.2k
Jane Parry United Kingdom 17 553 0.3× 247 0.3× 328 0.5× 158 0.3× 126 0.6× 50 891
Oluwaseun Falade‐Nwulia United States 20 1.1k 0.7× 393 0.5× 1.0k 1.6× 146 0.3× 59 0.3× 75 1.6k
Nick Walsh Australia 17 736 0.4× 262 0.3× 541 0.8× 102 0.2× 37 0.2× 42 950
Patrick Coffié Ivory Coast 20 630 0.4× 771 1.0× 184 0.3× 128 0.2× 64 0.3× 73 1.2k
A G Bird United Kingdom 14 447 0.3× 270 0.4× 81 0.1× 99 0.2× 158 0.7× 30 765
Jialun Zhou Australia 21 596 0.4× 732 1.0× 95 0.1× 123 0.2× 77 0.4× 30 1.2k
Sara Lodi United States 18 473 0.3× 534 0.7× 61 0.1× 158 0.3× 73 0.3× 69 1.0k

Countries citing papers authored by Sue Currie

Since Specialization
Citations

This map shows the geographic impact of Sue Currie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sue Currie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sue Currie more than expected).

Fields of papers citing papers by Sue Currie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sue Currie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sue Currie. The network helps show where Sue Currie may publish in the future.

Co-authorship network of co-authors of Sue Currie

This figure shows the co-authorship network connecting the top 25 collaborators of Sue Currie. A scholar is included among the top collaborators of Sue Currie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sue Currie. Sue Currie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hasanpourghadi, Mohadeseh, Zhiquan Xiang, Andrew Luber, et al.. (2024). A therapeutic HBV vaccine containing a checkpoint modifier enhances CD8+ T cell and antiviral responses. JCI Insight. 9(21). 3 indexed citations
2.
Erbe, Amy K., Jennifer Birstler, KyungMann Kim, et al.. (2023). Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial. Cancer Immunology Immunotherapy. 72(7). 2099–2111. 2 indexed citations
3.
Tannir, Nizar M., Adi Diab, Mario Sznol, et al.. (2022). Bempegaldesleukin plus nivolumab in first-line renal cell carcinoma: results from the PIVOT-02 study. Journal for ImmunoTherapy of Cancer. 10(4). e004419–e004419. 21 indexed citations
4.
Ertl, Hildegund C.J., Sue Currie, & David M. Livermore. (2022). Back to the Future: Can Vaccines Win the Long-Term Fight Against COVID-19?. Frontiers in Public Health. 10. 929445–929445. 1 indexed citations
5.
Siefker‐Radtke, Arlene O., Adi Diab, Mario Sznol, et al.. (2022). Bempegaldesleukin plus Nivolumab in First-line Metastatic Urothelial Carcinoma: Results from PIVOT-02. European Urology. 82(4). 365–373. 14 indexed citations
6.
Ertl, Hildegund C.J., Sue Currie, & Andrew Luber. (2022). Restricting use of adenovirus vector-based COVID vaccines could endanger public and global health. Frontiers in Immunology. 13. 985382–985382. 2 indexed citations
7.
Yee, Helen S., Sue Currie, Kathryn Tortorice, et al.. (2011). Retreatment of Hepatitis C with Consensus Interferon and Ribavirin After Nonresponse or Relapse to Pegylated Interferon and Ribavirin: A National VA Clinical Practice Study. Digestive Diseases and Sciences. 56(8). 2439–2448. 5 indexed citations
8.
Monto, Alexander, Sue Currie, & Teresa L. Wright. (2008). Liver Disease in Injection Drug Users with Hepatitis C, With and Without HIV Coinfection. Journal of Addictive Diseases. 27(2). 49–59. 12 indexed citations
9.
Cheung, Ramsey, Sue Currie, Hui Shen, et al.. (2008). Can We Predict the Degree of Fibrosis in Chronic Hepatitis C Patients Using Routine Blood Tests in Our Daily Practice?. Journal of Clinical Gastroenterology. 42(7). 827–834. 36 indexed citations
10.
Hu, Ke‐Qin, Sue Currie, Hui Shen, et al.. (2007). Clinical Implications of Hepatic Steatosis in Patients with Chronic Hepatitis C: A Multicenter Study of U.S. Veterans. Digestive Diseases and Sciences. 52(2). 570–578. 20 indexed citations
11.
Currie, Sue, James C. Ryan, Daniel Tracy, et al.. (2007). A prospective study to examine persistent HCV reinfection in injection drug users who have previously cleared the virus. Drug and Alcohol Dependence. 93(1-2). 148–154. 47 indexed citations
12.
Tsui, Judith I., Sue Currie, Hui Shen, et al.. (2007). Treatment Eligibility and Outcomes in Elderly Patients with Chronic Hepatitis C: Results from the VA HCV-001 Study. Digestive Diseases and Sciences. 53(3). 809–814. 25 indexed citations
13.
Seal, Karen H., Sue Currie, Hui Shen, et al.. (2007). Hepatitis C Treatment Candidacy and Outcomes Among 4318 US Veterans With Chronic Hepatitis C Virus Infection. Journal of Clinical Gastroenterology. 41(2). 199–205. 25 indexed citations
14.
Bini, Edmund J., Sue Currie, Hui Shen, et al.. (2006). National Multicenter Study of HIV Testing and HIV Seropositivity in Patients With Chronic Hepatitis C Virus Infection. Journal of Clinical Gastroenterology. 40(8). 732–739. 11 indexed citations
15.
Anand, Bhupinder S., Sue Currie, Eric Dieperink, et al.. (2006). Alcohol Use and Treatment of Hepatitis C Virus: Results of a National Multicenter Study. Gastroenterology. 130(6). 1607–1616. 115 indexed citations
16.
Fox, Rena K., Sue Currie, Jennifer L. Evans, et al.. (2005). Hepatitis C Virus Infection among Prisoners in the California State Correctional System. Clinical Infectious Diseases. 41(2). 177–186. 92 indexed citations
17.
Cheung, Ramsey, Sue Currie, Hui Shen, et al.. (2005). Chronic Hepatitis C in Latinos: Natural History, Treatment Eligibility, Acceptance, and Outcomes. The American Journal of Gastroenterology. 100(10). 2186–2193. 60 indexed citations
18.
Tyndall, Mark, Sue Currie, Patricia M. Spittal, et al.. (2003). Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS. 17(6). 887–893. 341 indexed citations
19.
Tyndall, Mark, Kevin J.P. Craib, Sue Currie, et al.. (2001). Impact of HIV Infection on Mortality in a Cohort of Injection Drug Users. JAIDS Journal of Acquired Immune Deficiency Syndromes. 28(4). 351–357. 118 indexed citations
20.
Schechter, Martin T., Steffanie A. Strathdee, Peter Cornelisse, et al.. (1999). Do needle exchange programmes increase the spread of HIV among injection drug users?: an investigation of the Vancouver outbreak. AIDS. 13(6). F45–F51. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026